Table 3.

Incidence of new disrupted luminal surface (DLS) or intraplaque hemorrhage (IPH) by baseline CAS (N=73 subjects without DLS or IPH at baseline).

		N (%†)
Baseline CAS	N (%*)	DLS	IPH	DLS or IPH
1	8 (11)	0 (0)	0 (0)	0 (0)
2	51 (70)	0 (0)	2 (4)	2 (4)
3	10 (14)	4 (40)	2 (20)	4 (40)
4	4 (5)	3 (75)	0 (0)	3 (75)
All	73 (100)	7 (10)	4 (5)	9 (12)
p for trend test		< 0.001	0.264	< 0.001

^*Percent of total (N=73).

^†Percent of subjects counted in each row (see second column).